Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Bayer takes Alzheimer’s diagnostic into pivotal trials

December 2, 2009 Research and Development Alz, Bayer, diagnostic

An imaging agent that can detect amyloid plaques in the brains of Alzheimer’s patients and so may provide an accurate …
News

Oxford BioTherapeutics appoints Dr Jim Cornett, Dr Jon Terrett and Dr Mike Gresser

December 2, 2009 Research and Development Oxford Biotherapeutics, appointment, research and development

Oxford BioTherapeutics has expanded its US operations, recruiting a number of senior industry leaders.Dr Jim Cornett will head up operations …
Appointment

New deal supports French pharma and biotech

December 1, 2009 Research and Development, Sales and Marketing France, biotech

 The French government has agreed a new deal with industry leaders to help the country’s pharma and biotech industries.President Sarkozy …
News

PPD buys BioDuro to get bigger in China

December 1, 2009 Research and Development CRO, China, em

Pharmaceutical Product Development (PPD) has expanded its capacity to offer drug development services in Asia once again with the acquisition …
News

Building value – is the pipeline all that matters?

December 1, 2009 Research and Development Les Rose, biotech, venture capital

Venture capital is a curious business and the global financial crisis in which we find ourselves has exposed some rather …
Feature

Incyte’s Novartis cancer drug deal could be worth $1bn

December 1, 2009 Research and Development Incyte, Novartis

Novartis has paid Incyte Corporation $150 million up front for the rights to two oral investigational hematology-oncology therapies.The first is …
News
ExonHit-Therapeutics-Herve100

Hervé Duchesne de Lamotte, chief financial officer, ExonHit Therapeutics

December 1, 2009 Research and Development ExonHit Therapeutics, appointment, research and development

ExonHit Therapeutics appoints Hervé Duchesne de Lamotte chief financial officer.The Paris-based company develops innovative molecular diagnostic tests and therapeutics for …
Appointment

GSK licences smoking vaccine candidate

November 30, 2009 Research and Development GSK, Nabi, smoking, vaccines

GlaxoSmithKline Biologicals has signed a licensing agreement for a nicotine vaccine candidate currently in the first of two phase III …
News

Clinical research news in brief

November 30, 2009 Research and Development CRO, Clinipace, ICON, Parexel

Pharmafocus’ latest round-up of clinical research news includes a new US registry to aid patient recruitment, alliances for ICON, Parexel …
News

EMA: Aligning regulation with the lifecycle of medicines

November 30, 2009 Research and Development EMA, EMEA, Thomas Lönngren, regulatory affairs

The European Agency for the Evaluation of Medicinal Products was set up in 1995 in London’s Docklands, an isolated eastern …
Feature

Roche invests in Spanish genome project

November 27, 2009 Research and Development Roche, Spain, genomics

Roche is investing in a Spanish health authority programme to analyse the genomes of people with rare diseases.The pharma company …
News

Pfizer UK’s Zubair Hussain appointed president-elect of TOPRA

November 27, 2009 Research and Development, Sales and Marketing Zubair Hussain, appointment, appointments, research and development, sales and marketing, topra

Pfizer UK’s Zubair Hussain has been appointed president-elect of global regulatory affairs organisation TOPRA.
Appointment

Dr Jan Lundberg to succeed Dr Steven Paul as head of Lilly Research Laboratories

November 27, 2009 Research and Development AstraZeneca, appointment, appt, lilly, research and development

Dr Jan Lundberg has been appointed executive VP, science and technology, and president of Lilly Research Laboratories.He will succeed Dr …
Appointment
MerckKgAaHQ

Merck Serono opens Beijing R&D centre

November 24, 2009 Research and Development China, Merck Serono, em

 China’s allure for pharma companies continues unabated with Merck Serono’s opening of a research and development centre in Beijing. The …
News
logo

Sanofi expands antibody venture with Regeneron

November 12, 2009 Research and Development Regeneron, Sanofi

 Sanofi-Aventis has put more financial muscle behind its partnership with Regeneron for the development of monoclonal antibody-based drugs, boosting its …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026